Pharmacogenetic workup of perioperative serotonin syndrome

Nicole C. Beatty, Wayne T. Nicholson, Loralie J. Langman, Timothy B Curry, John H. Eisenach

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Serotonin syndrome is gaining attention in perioperative and chronic pain settings due to the growing prevalence of multimodal therapies that increase serotonin levels and thereby heighten patient risk. A patient's genetic make-up may further increase the risk of serotonin syndrome. A case of serotonin syndrome on emergence after general anesthesia is presented. A subsequent cytochrome P4502D6 genetic test result suggested a potential alteration in metabolism. For this patient, who was taking combination antidepressant medications and receiving common perioperative medicines, additive pharmacodynamic effects converged with a pharmacogenetic predisposition, resulting in serotonin syndrome.

Original languageEnglish (US)
Pages (from-to)662-665
Number of pages4
JournalJournal of Clinical Anesthesia
Volume25
Issue number8
DOIs
StatePublished - Dec 2013

Fingerprint

Serotonin Syndrome
Pharmacogenetics
Cytochromes
Chronic Pain
General Anesthesia
Antidepressive Agents
Serotonin

Keywords

  • Duloxetine
  • Multimodal therapy
  • P4502D6 chromosome
  • Perioperative serotonin syndrome
  • Pharmacogenetics

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Pharmacogenetic workup of perioperative serotonin syndrome. / Beatty, Nicole C.; Nicholson, Wayne T.; Langman, Loralie J.; Curry, Timothy B; Eisenach, John H.

In: Journal of Clinical Anesthesia, Vol. 25, No. 8, 12.2013, p. 662-665.

Research output: Contribution to journalArticle

Beatty, Nicole C. ; Nicholson, Wayne T. ; Langman, Loralie J. ; Curry, Timothy B ; Eisenach, John H. / Pharmacogenetic workup of perioperative serotonin syndrome. In: Journal of Clinical Anesthesia. 2013 ; Vol. 25, No. 8. pp. 662-665.
@article{d10e8e16efce49c993fbadc1fa834f70,
title = "Pharmacogenetic workup of perioperative serotonin syndrome",
abstract = "Serotonin syndrome is gaining attention in perioperative and chronic pain settings due to the growing prevalence of multimodal therapies that increase serotonin levels and thereby heighten patient risk. A patient's genetic make-up may further increase the risk of serotonin syndrome. A case of serotonin syndrome on emergence after general anesthesia is presented. A subsequent cytochrome P4502D6 genetic test result suggested a potential alteration in metabolism. For this patient, who was taking combination antidepressant medications and receiving common perioperative medicines, additive pharmacodynamic effects converged with a pharmacogenetic predisposition, resulting in serotonin syndrome.",
keywords = "Duloxetine, Multimodal therapy, P4502D6 chromosome, Perioperative serotonin syndrome, Pharmacogenetics",
author = "Beatty, {Nicole C.} and Nicholson, {Wayne T.} and Langman, {Loralie J.} and Curry, {Timothy B} and Eisenach, {John H.}",
year = "2013",
month = "12",
doi = "10.1016/j.jclinane.2013.06.005",
language = "English (US)",
volume = "25",
pages = "662--665",
journal = "Journal of Clinical Anesthesia",
issn = "0952-8180",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Pharmacogenetic workup of perioperative serotonin syndrome

AU - Beatty, Nicole C.

AU - Nicholson, Wayne T.

AU - Langman, Loralie J.

AU - Curry, Timothy B

AU - Eisenach, John H.

PY - 2013/12

Y1 - 2013/12

N2 - Serotonin syndrome is gaining attention in perioperative and chronic pain settings due to the growing prevalence of multimodal therapies that increase serotonin levels and thereby heighten patient risk. A patient's genetic make-up may further increase the risk of serotonin syndrome. A case of serotonin syndrome on emergence after general anesthesia is presented. A subsequent cytochrome P4502D6 genetic test result suggested a potential alteration in metabolism. For this patient, who was taking combination antidepressant medications and receiving common perioperative medicines, additive pharmacodynamic effects converged with a pharmacogenetic predisposition, resulting in serotonin syndrome.

AB - Serotonin syndrome is gaining attention in perioperative and chronic pain settings due to the growing prevalence of multimodal therapies that increase serotonin levels and thereby heighten patient risk. A patient's genetic make-up may further increase the risk of serotonin syndrome. A case of serotonin syndrome on emergence after general anesthesia is presented. A subsequent cytochrome P4502D6 genetic test result suggested a potential alteration in metabolism. For this patient, who was taking combination antidepressant medications and receiving common perioperative medicines, additive pharmacodynamic effects converged with a pharmacogenetic predisposition, resulting in serotonin syndrome.

KW - Duloxetine

KW - Multimodal therapy

KW - P4502D6 chromosome

KW - Perioperative serotonin syndrome

KW - Pharmacogenetics

UR - http://www.scopus.com/inward/record.url?scp=84890411104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890411104&partnerID=8YFLogxK

U2 - 10.1016/j.jclinane.2013.06.005

DO - 10.1016/j.jclinane.2013.06.005

M3 - Article

C2 - 24096103

AN - SCOPUS:84890411104

VL - 25

SP - 662

EP - 665

JO - Journal of Clinical Anesthesia

JF - Journal of Clinical Anesthesia

SN - 0952-8180

IS - 8

ER -